[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Wound Treatments - France

April 2010 | 49 pages | ID: W3CC09E58F6EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In 2009, sales of wound treatments increased by 1% in current value terms to reach EUR114mn. Wound treatment value sales were boosted by sticking plasters, where innovative products offering greater technical advances and patient comfort registered the best performance.

Euromonitor International's Wound Treatments Products in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage:Other Wound Treatments, Sticking Plasters

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health industry;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Executive Summary
Consumer Health Lacks Dynamism
Launch of OTC Obesity Causes Controversy in Consumer Health
Consumer Health Characterised by Fragmented Competitive Environment
Chemists/pharmacies Continue To Dominate Retail Channels
Lack of Growth Will Cause Stagnation
Key Trends and Developments
Self-service: Old Habits Die Hard As Consumers Prefer Advice From Chemists/pharmacists
Consumer Health Battles Against 'alicaments', Highly Functional Foods
Stressful, Busy Lifestyles Influence Natural Choices
Fat Fighting - OTC Obesity Category Launched With New Product Alli
Consumer Health Is Fragmented But Targeted
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Consumer Health Company Shares by Value 2005-2009
  Table 6 Consumer Health Brand Shares by Value 2006-2009
  Table 7 Penetration of Private Label by Sector 2004-2009
  Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication/self-care and Preventive Medicine
Generics
Switches
  Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Sector and Subsector Definitions
  Summary 2 Research Sources
Arkopharma Sa, Laboratoires Pharmaceutiques
Strategic Direction
Key Facts
  Summary 3 Laboratoires Pharmaceutiques Arkopharma SA: Key Facts
  Summary 4 Laboratoires Pharmaceutiques Arkopharma SA: Operational Indicators
Company Background
Competitive Positioning
  Summary 5 Laboratoires Pharmaceutiques Arkopharma SA: Competitive Position 2009
Beaufour-ipsen SA
Strategic Direction
Key Facts
  Summary 6 Beaufour-Ipsen SA: Key Facts
  Summary 7 Beaufour-Ipsen SA: Operational Indicators
Company Background
Production
  Summary 8 Beaufour-Ipsen SA: Production Statistics
Competitive Positioning
  Summary 9 Beaufour-Ipsen SA: Competitive Position 2009
Cooper SA
Strategic Direction
Key Facts
  Summary 10 Cooper SA: Key Facts
  Summary 11 Cooper SA: Operational Indicators
Company Background
Production
  Summary 12 Cooper SA: Production Statistics
Competitive Positioning
  Summary 13 Cooper SA: Competitive Position 2009
GlaxoSmithKline Santé Grand Public Sas
Strategic Direction
Key Facts
  Summary 14 GlaxoSmithKline Santé Grand Public SAS: Key Facts
  Summary 15 GlaxoSmithKline Santé Grand Public SAS: Operational Indicators
Company Background
Production
  Summary 16 GlaxoSmithKline France: Production Statistics
Competitive Positioning
  Summary 17 GlaxoSmithKline Santé Grand Public SAS: Competitive Position 2009
Juva Santé, Groupe
Strategic Direction
Key Facts
  Summary 18 Laboratoires Juva Santé: Key Facts
Company Background
Production
  Summary 20 Laboratoires Juva Santé: Production Statistics
Competitive Positioning
  Summary 21 Laboratoires Juva Santé: Competitive Position 2009
Laboratoires Mcneil
Strategic Direction
Key Facts
  Summary 22 Laboratoires McNeil: Key Facts
  Summary 23 Laboratoires McNeil: Operational Indicators
Company Background
Competitive Positioning
  Summary 24 Laboratoires McNeil: Competitive Position 2009
Pierre Fabre Sa, Laboratoires
Strategic Direction
Key Facts
  Summary 25 Laboratoires Pierre Fabre SA: Key Facts
  Summary 26 Laboratoires Pierre Fabre SA: Operational Indicators
Company Background
Production
  Summary 27 Laboratoires Pierre Fabre SA: Production Statistics
Competitive Positioning
  Summary 28 Laboratoires Pierre Fabre SA: Competitive Position 2009
Théraplix SA
Strategic Direction
Key Facts
  Summary 29 Théraplix SA: Key Facts
Company Background
Competitive Positioning
  Summary 30 Théraplix SA: Competitive Position 2009
Upsa, Laboratoires
Strategic Direction
Key Facts
  Summary 31 Laboratoires UPSA: Key Facts
  Summary 32 Laboratoires UPSA: Operational Indicators
Company Background
Production
  Summary 33 Laboratoires UPSA: Production Statistics
Competitive Positioning
  Summary 34 Laboratoires UPSA: Competitive Position 2009
Urgo, Laboratoires
Strategic Direction
Key Facts
  Summary 35 Laboratoires Urgo: Key Facts
  Summary 36 Laboratoires Urgo: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 37 Laboratoires Urgo: Competitive Position 2009
Trends
Category Data
  Table 12 Sales of Wound Treatments by Subsector: Value 2004-2009
  Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
  Table 14 Wound Treatments Company Shares by Value 2005-2009
  Table 15 Wound Treatments Brand Shares by Value 2006-2009
  Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
  Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014


More Publications